Key Insights

Highlights

Success Rate

84% trial completion

Published Results

13 trials with published results (26%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

10.0%

5 terminated out of 50 trials

Success Rate

84.4%

-2.1% vs benchmark

Late-Stage Pipeline

20%

10 trials in Phase 3/4

Results Transparency

48%

13 of 27 completed with results

Key Signals

13 with results84% success

Data Visualizations

Phase Distribution

42Total
Not Applicable (21)
Early P 1 (1)
P 1 (2)
P 2 (8)
P 3 (1)
P 4 (9)

Trial Status

Completed27
Unknown9
Terminated5
Not Yet Recruiting4
Recruiting2
Suspended1

Trial Success Rate

84.4%

Benchmark: 86.5%

Based on 27 completed trials

Clinical Trials (50)

Showing 20 of 20 trials
NCT05269849Phase 2Completed

Sirolimus for Nosebleeds in HHT

NCT07531472Not ApplicableNot Yet RecruitingPrimary

Outcome of Hyaluronic Acid Gel Versus Petroleum Jelly in Treatment of Epistaxis

NCT07511192Phase 4Not Yet RecruitingPrimary

The Efficacy of Local Application of B-sitosterol Versus Vasline in Cases of Idiopathic Epistaxis

NCT03850964Phase 2Active Not Recruiting

Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz)

NCT06985108Not ApplicableCompletedPrimary

Comparison of Nasal Endotracheal Tube and Spiral Tube for Nasotracheal Intubation in Pediatric Patients

NCT06259292Recruiting

Comprehensive HHT Outcomes Registry of the United States (CHORUS)

NCT06906861CompletedPrimary

Epistaxis in Patients Receiving Oral Anticoagulants and Antiplatelet: Prevalence Risk Factors at a Tertiary Care Hospital in Nepal

NCT06836102Not ApplicableNot Yet RecruitingPrimary

Usage of Orange Peel Extract in Management of Epistaxis

NCT06657053Not Yet RecruitingPrimary

Risk Factors of Epistaxis Recurrence in Adults

NCT02517294Not ApplicableCompletedPrimary

, "Mucosal Injury During Nasotracheal Intubation for Dental Procedures in Children-does the Tube Design Matter?"

NCT05343650Phase 4Unknown

NOVAPAK Nasal Packing in Shellfish Allergic Patients

NCT05281952Not ApplicableRecruitingPrimary

Medico-economic Evaluation of Management Strategies for Severe Epistaxis

NCT05334017Phase 4CompletedPrimary

Xylometazoline and Cocaine for Nasal Vasoconstriction

NCT02488135Not ApplicableCompletedPrimary

Management of Persistent Epistaxis Using Floseal Hemostatic Matrix

NCT03850730Phase 1Unknown

Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia

NCT04426409Not ApplicableCompletedPrimary

Nasal Ointment on Epistaxis of Nasotracheal Intubation in Children

NCT04167085Phase 4CompletedPrimary

NOrth American Study for the Treatment of Recurrent epIstaxis With DoxycycLine: The NOSTRIL Trial

NCT02930941Phase 4TerminatedPrimary

Topical Intranasal Tranexamic Acid for Epistaxis in the Emergency Department

NCT03740620Not ApplicableCompletedPrimary

The Effect of Bevel Direction on the Pathway of the Nasotracheal Tube

NCT02389959Phase 4Completed

Intranasal Bevacizumab for HHT-Related Epistaxis

Scroll to load more

Research Network

Activity Timeline